Literature DB >> 12216056

The epidemiology of mental retardation: challenges and opportunities in the new millennium.

Helen Leonard1, Xingyan Wen.   

Abstract

There are a number of problems and challenges in relating the science of epidemiology to mental retardation (MR). These relate to how MR is defined and classified and how these definitions may change over time. These as well as other differences in ascertainment sources and methods need to be considered when comparing MR prevalence over time and place. On the other hand, advances in technology also provide new and efficient methods of data collection both by data linkage and by use of web-based methods to study rare diseases. While prevalence studies have not been individually reviewed, we have examined the range of data including recent studies relating to how prevalence differs according to age, gender, social class and ethnicity. Some problems with available etiological classification systems have been identified. Recent etiological studies, most of which use different classification systems, have been reviewed and explanations have been postulated to account for differences in results. Individual risk factors for MR are considered whilst the option of considering a population as opposed to a high risk strategy to MR prevention is raised. This might well involve improving the social milieu surrounding the occurrence of individual risk factors. The impact of biotechnological advances such as antenatal and neonatal screening and assisted reproduction on MR are discussed. The issue of how inequalities in access to technology may impact on case identification and even have the potential to further widen inequalities is raised. The importance of extending the use of epidemiological tools to study the social, health and economic burden of MR is also emphasized. However, in order to apply to MR the "prevention-intervention-research" cycle, which surely underpins all epidemiology, it is vital to ensure that the methodological challenges we raise are adequately addressed. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12216056     DOI: 10.1002/mrdd.10031

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  149 in total

1.  De Novo Mutations in CHAMP1 Cause Intellectual Disability with Severe Speech Impairment.

Authors:  Maja Hempel; Kirsten Cremer; Charlotte W Ockeloen; Klaske D Lichtenbelt; Johanna C Herkert; Jonas Denecke; Tobias B Haack; Alexander M Zink; Jessica Becker; Eva Wohlleber; Jessika Johannsen; Bader Alhaddad; Rolph Pfundt; Sigrid Fuchs; Dagmar Wieczorek; Tim M Strom; Koen L I van Gassen; Tjitske Kleefstra; Christian Kubisch; Hartmut Engels; Davor Lessel
Journal:  Am J Hum Genet       Date:  2015-09-03       Impact factor: 11.025

Review 2.  Genetic studies in intellectual disability and related disorders.

Authors:  Lisenka E L M Vissers; Christian Gilissen; Joris A Veltman
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

3.  MAN1B1 Mutation Leads to a Recognizable Phenotype: A Case Report and Future Prospects.

Authors:  Sabine Hoffjan; Jörg T Epplen; André Reis; Rami Abou Jamra
Journal:  Mol Syndromol       Date:  2015-03-04

4.  SOBP is mutated in syndromic and nonsyndromic intellectual disability and is highly expressed in the brain limbic system.

Authors:  Efrat Birk; Adi Har-Zahav; Chiara M Manzini; Metsada Pasmanik-Chor; Liora Kornreich; Christopher A Walsh; Konrad Noben-Trauth; Adi Albin; Amos J Simon; Laurence Colleaux; Yair Morad; Limor Rainshtein; David J Tischfield; Peter Wang; Nurit Magal; Idit Maya; Noa Shoshani; Gideon Rechavi; Doron Gothelf; Gal Maydan; Mordechai Shohat; Lina Basel-Vanagaite
Journal:  Am J Hum Genet       Date:  2010-10-28       Impact factor: 11.025

5.  AGTR2 in brain development and function.

Authors:  Virginie S Vervoort; Greagory Guzauskas; John Archie; Charles E Schwartz; Roger E Stevenson; Anand K Srivastava
Journal:  Am J Med Genet A       Date:  2006-03-01       Impact factor: 2.802

6.  The prevalence and incidence of mental ill-health in adults with autism and intellectual disabilities.

Authors:  Craig A Melville; Sally-Ann Cooper; Jill Morrison; Elita Smiley; Linda Allan; Alison Jackson; Janet Finlayson; Dipali Mantry
Journal:  J Autism Dev Disord       Date:  2008-02-29

Review 7.  Balanced translocations in mental retardation.

Authors:  Geert Vandeweyer; R Frank Kooy
Journal:  Hum Genet       Date:  2009-04-05       Impact factor: 4.132

8.  Biallelic variants in FBXL3 cause intellectual disability, delayed motor development and short stature.

Authors:  Muhammad Ansar; Sohail Aziz Paracha; Alessandro Serretti; Muhammad T Sarwar; Jamshed Khan; Emmanuelle Ranza; Emilie Falconnet; Justyna Iwaszkiewicz; Sayyed Fahim Shah; Azhar Ali Qaisar; Federico A Santoni; Vincent Zoete; Andre Megarbane; Jawad Ahmed; Roberto Colombo; Periklis Makrythanasis; Stylianos E Antonarakis
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

9.  CC2D2A, encoding a coiled-coil and C2 domain protein, causes autosomal-recessive mental retardation with retinitis pigmentosa.

Authors:  Abdul Noor; Christian Windpassinger; Megha Patel; Beata Stachowiak; Anna Mikhailov; Matloob Azam; Muhammad Irfan; Zahid Kamal Siddiqui; Farooq Naeem; Andrew D Paterson; Muhammad Lutfullah; John B Vincent; Muhammad Ayub
Journal:  Am J Hum Genet       Date:  2008-04       Impact factor: 11.025

10.  A rational approach to the child with mental retardation for the paediatrician.

Authors:  Jean-François Lemay; Anthony R Herbert; Deborah M Dewey; A Micheil Innes
Journal:  Paediatr Child Health       Date:  2003-07       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.